C-Level corporate, investment banking, entrepreneurial, multinational, investor relations and credit rating experience in life sciences, technology ventures, private equity. Co-Founder, private equity funds of funds GP. Advisor to Abbvie, HP, McKinsey, Goldman Sachs, Thomas H. Lee, Citibank, Brookings. MIT-life sciences/IP trained, Brown and Sussex technology development graduate.

Expert in protein biophysics, 2D IR correlation spectroscopy and protein aggregation; expert lecturer FDA, PEGS, PepTalk, & ICAVS. Inventor, PDS method patent, sampling device for spectral data acquisition and analysis. Upstream & downstream processing experience. Oversees design, development and validation of bioinstrumentation, regulatory experts. Mayo Clinic Post Doc, Pharmacology and Molecular Biology. Ph.D. Rutgers, Physical Biochemistry.

Twenty years commercialization of life science technologies, with focus on innovative tools and services for the pharmaceutical industry. Track record of driving growth for emerging organizations, including as a founder of BIOCIUS, through to acquisition by, and integration into, Agilent Technologies. Strong network across the Life Science area, recently as Senior Director of Business Development at SCIEX, a Danaher company.